Development of an ultrasound-capable phantom with patient-specific 3D-printed vascular anatomy to simulate peripheral endovascular interventions.


Journal

Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft
ISSN: 1618-0402
Titre abrégé: Ann Anat
Pays: Germany
ID NLM: 100963897

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 04 04 2020
revised: 26 05 2020
accepted: 27 05 2020
pubmed: 26 6 2020
medline: 28 7 2021
entrez: 26 6 2020
Statut: ppublish

Résumé

Today, ultrasound-guided peripheral endovascular interventions have the potential to be an alternative to conventional interventions that are still X-ray and contrast agent based. For the further development of this approach, a research environment is needed that represents the individual patient-specific endovascular properties as realistically as possible. Aim of the project was the construction of a phantom that combines ultrasound capabilities and the possibility to simulate peripheral endovascular interventions. We designed a modular ultrasound-capable phantom with exchangeable patient specific vascular anatomy. For the manufacturing of the vascular pathologies, we used 3D printing technology. Subsequently, we evaluated the constructed simulator with regards to its application for endovascular development projects. We developed an ultrasound-capable phantom with an exchangeable 3D-printed segment of the femoral artery. This modality allows the study of several patient-specific 3D-printed pathologies. Compared to the flow properties of a human artery (male; age 28) the phantom shows realistic flow properties in the duplex ultrasound image. We proved the feasibility of the simulator by performing an ultrasound-guided endovascular procedure. Overall, the simulator showed realistic intervention conditions. With the help of the constructed simulator, new endovascular procedures and navigation systems, such as ultrasound-guided peripheral vascular interventions, can be further developed. Additionally, in our opinion, the use of such simulators can also reduce the need for animal experiments.

Identifiants

pubmed: 32585296
pii: S0940-9602(20)30107-2
doi: 10.1016/j.aanat.2020.151563
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151563

Informations de copyright

Copyright © 2020 Elsevier GmbH. All rights reserved.

Auteurs

M Kaschwich (M)

Department of Surgery, Division of Vascular and Endovascular Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany. Electronic address: mark.kaschwich@uksh.de.

A Dell (A)

Department of Surgery, Division of Vascular and Endovascular Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.

F Matysiak (F)

Department of Surgery, Division of Vascular and Endovascular Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.

J Bouchagiar (J)

Department of Surgery, Division of Vascular and Endovascular Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.

A Bayer (A)

Institute of Anatomy, Christian-Albrechts University of Kiel, Kiel, Germany.

M Scharfschwerdt (M)

Department of Cardiac and Thoracic Vascular Surgery, University of Lübeck, Lübeck, Germany.

F Ernst (F)

Institute for Robotics and Cognitive Systems, University of Lübeck, Ratzeburger Allee 160, Lübeck 23562, Germany.

M Kleemann (M)

Department of Surgery, Division of Vascular and Endovascular Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.

M Horn (M)

Department of Surgery, Division of Vascular and Endovascular Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH